| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/25/2001 | CA2392065A1 Sunflower rhogap, lox, adh, and scip-1 polynucleotides and methods of use |
| 05/25/2001 | CA2392051A1 Transgenic mice expressing fluorescent protein under the control of the nestin promoter |
| 05/25/2001 | CA2391998A1 Method for assessing genotoxicity of a compound |
| 05/25/2001 | CA2391971A1 Methods and means for regulation of gene expression |
| 05/25/2001 | CA2391925A1 Antibodies |
| 05/25/2001 | CA2391908A1 Novel polypeptides and nucleic acids encoding same |
| 05/25/2001 | CA2391906A1 Nucleic acid construct for optimized production of products |
| 05/25/2001 | CA2391885A1 Polypeptides and nucleic acids encoding same |
| 05/25/2001 | CA2391881A1 Transfer compounds, production and use thereof |
| 05/25/2001 | CA2391739A1 Site-directed mutagenesis of escherichia coli phytase |
| 05/25/2001 | CA2391669A1 Mammalian genes: related reagents and methods |
| 05/25/2001 | CA2391651A1 Protein c derivatives |
| 05/25/2001 | CA2391622A1 Inhibiting gene expression with dsrna |
| 05/25/2001 | CA2391593A1 Selectable cell surface marker genes |
| 05/25/2001 | CA2391571A1 Method for rapid and accurate identification of microorganisms |
| 05/25/2001 | CA2391569A1 Environmental stress tolerance genes |
| 05/25/2001 | CA2391560A1 The genome of the hiv-1 inter-subtype (c/b') and use thereof |
| 05/25/2001 | CA2391558A1 Immunological detection of rna:dna hybrids on microarrays |
| 05/25/2001 | CA2391531A1 Placental human neurokinin b precursor |
| 05/25/2001 | CA2391530A1 Tr3-specific binding agents and methods for their use |
| 05/25/2001 | CA2391504A1 New olfactory receptor polypeptides and dna sequences thereof |
| 05/25/2001 | CA2391450A1 Targeted delivery of therapeutic and diagnostic moieties |
| 05/25/2001 | CA2391446A1 Plant biochemistry-related genes |
| 05/25/2001 | CA2391443A1 Plant developmental genes |
| 05/25/2001 | CA2391403A1 Novel protein and dna thereof |
| 05/25/2001 | CA2391399A1 Oleosins in cocoa |
| 05/25/2001 | CA2391212A1 Methods and compositions for identifying disease markers |
| 05/25/2001 | CA2391128A1 A method of making transgenic plants expressing a cecropin-hybrid cationic peptide imparting broad-spectrum pathogen resistance |
| 05/25/2001 | CA2391084A1 High order nucleic acid based structures |
| 05/25/2001 | CA2391080A1 Erythropoietin forms with improved properties |
| 05/25/2001 | CA2390607A1 Materials and methods for detection and treatment of breast cancer |
| 05/25/2001 | CA2390600A1 Seed trait genes |
| 05/25/2001 | CA2390597A1 Pathogen tolerance genes |
| 05/25/2001 | CA2390594A1 Yield-related genes |
| 05/25/2001 | CA2390555A1 An animal model for studying hormone signalling and method of modulating the signalling |
| 05/25/2001 | CA2390548A1 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 05/25/2001 | CA2390547A1 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 05/25/2001 | CA2390292A1 Interferon gamma conjugates |
| 05/25/2001 | CA2390051A1 Thymidylate synthase polymorphism for predicting chemotherapeutic response |
| 05/25/2001 | CA2390031A1 Double-stranded rna receptor (dsrna-r) and methods relating thereto |
| 05/25/2001 | CA2389862A1 Human monoclonal antibody against tgf-.beta.ii receptor and medicinal use thereof |
| 05/25/2001 | CA2389851A1 Human igm antibodies to chemokine receptors |
| 05/25/2001 | CA2389662A1 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 05/25/2001 | CA2389613A1 Continuous-flow method for preparing microparticles |
| 05/25/2001 | CA2389569A1 Crystallizable compositions comprising a caspase-7 |
| 05/25/2001 | CA2389430A1 Srik a novel cell cycle protein associated with rip3 |
| 05/25/2001 | CA2389289A1 Mammalian toxicological response markers |
| 05/25/2001 | CA2388922A1 23 human secreted proteins |
| 05/25/2001 | CA2388865A1 Novel g protein-coupled receptors |
| 05/25/2001 | CA2388777A1 18 human secreted proteins |
| 05/25/2001 | CA2388703A1 Long oligonucleotide arrays |
| 05/25/2001 | CA2388563A1 Diagnosis kit, method and microarray for determining human detoxification capacity |
| 05/25/2001 | CA2388561A1 Method for the controlled implementation of complex pcr amplifications |
| 05/25/2001 | CA2386341A1 Heteroclitic analogs and related methods |
| 05/25/2001 | CA2385090A1 Cloning and characterization of the cap gene promoter |
| 05/25/2001 | CA2362913A1 Methods for using lactonohydrolases in baking |
| 05/25/2001 | CA2359758A1 Methods for conditional transgene expression and trait removal in plants |
| 05/25/2001 | CA2324496A1 New nucleotide sequences coding for the genes succ and sucd |
| 05/24/2001 | US20010001712 Causing apoptosis on myeloid cells through binding to the myeloid cells |
| 05/24/2001 | US20010001709 Methods for enhancing the production of viral vaccines in cell culture |
| 05/24/2001 | US20010001662 To treat a behavioral or psychological deficit such as caused by ischema in an animal; intracerebral transplantation; obtaining said cells from human fetus, immortalization of cells |
| 05/24/2001 | US20010001661 Gene delivery in various muscle cell types; gene therapy for expression of erythropoietin to treat blood disorders such as anemias, for example |
| 05/23/2001 | EP1101824A2 Detection of sequence variation of nucleic acid by shifted termination analysis |
| 05/23/2001 | EP1101821A1 Novel protein and its dna |
| 05/23/2001 | EP1101820A1 Pentraxin I and Pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 05/23/2001 | EP1101819A1 GENE Any-RF, DORMANCY REGULATORY SUBSTANCE, PROCESS FOR PRODUCING THE SAME AND CELL REGULATOR FOR VITAL CELLS |
| 05/23/2001 | EP1101771A1 Pathogen-induced genes from Capsicum annuum |
| 05/23/2001 | EP1101412A2 Use of a high-ester pectin in acidic, protein-containing foodstuffs |
| 05/23/2001 | EP1101112A2 Leptin-mediated gene-induction |
| 05/23/2001 | EP1101104A1 Spectral calibration of fluorescent polynucleotide separation apparatus |
| 05/23/2001 | EP1101102A2 Micro-system with multiple points for chemical or biological analysis |
| 05/23/2001 | EP1100973A1 Oligomers which inhibit expression of collagen genes |
| 05/23/2001 | EP1100972A1 Reversible inhibiting probes |
| 05/23/2001 | EP1100971A1 Wavelength-shifting probes and primers |
| 05/23/2001 | EP1100970A2 Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals |
| 05/23/2001 | EP1100969A1 Methods and compositions for the determination of protein function and identification of modulators thereof |
| 05/23/2001 | EP1100968A1 Genotyping human udp-glucuronosyltransferase 2b4 (ugt2b4), 2b7 (ugt2b7) and 2b15 (ugt2b15) genes |
| 05/23/2001 | EP1100967A2 DUPLICATIONS OF HUMAN CHROMOSOME 15q24-25 AND ANXIETY DISORDERS, DIAGNOSTIC METHODS FOR THEIR DETECTION |
| 05/23/2001 | EP1100965A1 Method of and composite for fluorescent in situ hybridization |
| 05/23/2001 | EP1100964A1 Gene sequence variances with utility in determining the treatment of disease |
| 05/23/2001 | EP1100963A2 Human ccr-2 gene polymorphisms |
| 05/23/2001 | EP1100962A1 Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases |
| 05/23/2001 | EP1100961A1 Genetic polymorphisms in the human neurokinin 2 receptor gene and their use in diagnosis and treatment of diseases |
| 05/23/2001 | EP1100958A2 Nucleic acid molecules with specific identification of native prp?sc , their production and the use thereof |
| 05/23/2001 | EP1100956A2 Process for identification of substances modulating urei dependent mechanisms of helicobacter pylori metabolism |
| 05/23/2001 | EP1100955A2 Agent and method for modulation of cell migration |
| 05/23/2001 | EP1100950A1 Gastrointestinal bacterial antibody factories |
| 05/23/2001 | EP1100949A1 Fusion products containing insoluble proteinaceous tag |
| 05/23/2001 | EP1100946A1 Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates |
| 05/23/2001 | EP1100945A2 Latency-active regulatory sequences of herpesviruses and lantency-inactive herpesviruses for gene transfer |
| 05/23/2001 | EP1100944A1 Targeted alphavirus and alphaviral vectors |
| 05/23/2001 | EP1100943A2 Herpesviral vectors for gene delivery |
| 05/23/2001 | EP1100942A2 Herpes virus vectors for dendritic cells |
| 05/23/2001 | EP1100941A2 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same |
| 05/23/2001 | EP1100940A2 Genes involved in tolerance to environmental stress |
| 05/23/2001 | EP1100939A1 Nucleic acid molecule coding for beta-amylase, plants synthesizing a modified starch, method of production and applications |
| 05/23/2001 | EP1100938A2 Modification of starch biosynthetic enzyme gene expression to produce starches in grain crops |
| 05/23/2001 | EP1100937A1 Plants which synthesize a modified starch, methods for producing the plants, their use, and the modified starch |
| 05/23/2001 | EP1100936A1 Methods and means to modulate programmed cell death in eukaryotic cells |
| 05/23/2001 | EP1100935A1 Mutant e.coli strains, and their use for producing recombinant polypeptides |